Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of ocular alignment on emmetropization in children <10 years with amblyopia.
Kulp MT, Foster NC, Holmes JM, Kraker RT, Melia BM, Repka MX, Tien DR; Pediatric Eye Disease Investigator Group. Kulp MT, et al. Among authors: holmes jm. Am J Ophthalmol. 2012 Aug;154(2):297-302.e1. doi: 10.1016/j.ajo.2012.02.035. Epub 2012 May 23. Am J Ophthalmol. 2012. PMID: 22633344 Free PMC article. Clinical Trial.
The Amblyopia Treatment Index.
Cole SR, Beck RW, Moke PS, Celano MP, Drews CD, Repka MX, Holmes JM, Birch EE, Kraker RT, Kip KE; Pediatric Eye Disease Investigator Group. Cole SR, et al. Among authors: holmes jm. J AAPOS. 2001 Aug;5(4):250-4. doi: 10.1067/mpa.2001.117097. J AAPOS. 2001. PMID: 11507585 Clinical Trial.
The amblyopia treatment study visual acuity testing protocol.
Holmes JM, Beck RW, Repka MX, Leske DA, Kraker RT, Blair RC, Moke PS, Birch EE, Saunders RA, Hertle RW, Quinn GE, Simons KA, Miller JM; Pediatric Eye Disease Investigator Group. Holmes JM, et al. Arch Ophthalmol. 2001 Sep;119(9):1345-53. doi: 10.1001/archopht.119.9.1345. Arch Ophthalmol. 2001. PMID: 11545641 Clinical Trial.
Amblyopia. Current clinical studies.
Holmes JM, Beck RW, Repka MX. Holmes JM, et al. Ophthalmol Clin North Am. 2001 Sep;14(3):393-8. doi: 10.1016/s0896-1549(05)70236-4. Ophthalmol Clin North Am. 2001. PMID: 11705138 Review.
Risk of amblyopia recurrence after cessation of treatment.
Holmes JM, Beck RW, Kraker RT, Astle WF, Birch EE, Cole SR, Cotter SA, Donahue S, Everett DF, Hertle RW, Keech RV, Paysse E, Quinn GF, Repka MX, Scheiman MM; Pediatric Eye Disease Investigator Group. Holmes JM, et al. J AAPOS. 2004 Oct;8(5):420-8. doi: 10.1016/S1091853104001612. J AAPOS. 2004. PMID: 15492733 Clinical Trial.
A randomized trial of atropine regimens for treatment of moderate amblyopia in children.
Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, Hertle RW, Holmes JM, Quinn GE, Sala NA, Scheiman MM, Stager DR Sr, Wallace DK; Pediatric Eye Disease Investigator Group. Repka MX, et al. Among authors: holmes jm. Ophthalmology. 2004 Nov;111(11):2076-85. doi: 10.1016/j.ophtha.2004.04.032. Ophthalmology. 2004. PMID: 15522375 Clinical Trial.
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
Repka MX, Wallace DK, Beck RW, Kraker RT, Birch EE, Cotter SA, Donahue S, Everett DF, Hertle RW, Holmes JM, Quinn GE, Scheiman MM, Weakley DR; Pediatric Eye Disease Investigator Group. Repka MX, et al. Among authors: holmes jm. Arch Ophthalmol. 2005 Feb;123(2):149-57. doi: 10.1001/archopht.123.2.149. Arch Ophthalmol. 2005. PMID: 15710809 Clinical Trial.
393 results